Title : Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide).

Pub. Date : 1989 Apr

PMID : 2498455






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation (tolbutamide) to a second generation sulphonylurea (gliclazide). Gliclazide plasminogen activator, tissue type Homo sapiens
2 All 10 patients responded on the change in treatment to gliclazide with an increase in activity of t-PA. Gliclazide plasminogen activator, tissue type Homo sapiens
3 The concentration in plasma of t-PA antigen under basal conditions and after stimulation (venous occlusion) increased significantly during the period of treatment with gliclazide. Gliclazide plasminogen activator, tissue type Homo sapiens
4 In contrast to these findings seven patients with marked activities of t-PA during treatment with tolbutamide retained unchanged levels of the variables reported above after a change in treatment to gliclazide. Gliclazide plasminogen activator, tissue type Homo sapiens